3.22.2.2 html 295 334 1 false 79 0 false 5 false false R1.htm 100000 - Document - Cover Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DocumentCover Cover Cover 1 false false R2.htm 100010 - Statement - Consolidated Balance Sheets (Unaudited) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_StatementConsolidatedBalanceSheetsUnaudited Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 100030 - Statement - Consolidated Balance Sheets (Unaudited) (Parenthetical) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_StatementConsolidatedBalanceSheetsUnauditedParenthetical Consolidated Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 100040 - Statement - Consolidated Statements of Operations (Unaudited) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_StatementConsolidatedStatementsOfOperationsUnaudited Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 100050 - Statement - Consolidated Statements of Comprehensive Loss (Unaudited) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/StatementConsolidatedStatementsOfComprehensiveLossUnaudited Consolidated Statements of Comprehensive Loss (Unaudited) Statements 5 false false R6.htm 100060 - Statement - Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_StatementConsolidatedStatementsOfStockholdersEquityUnaudited Consolidated Statements of Stockholders' Equity (Unaudited) Statements 6 false false R7.htm 100070 - Statement - Consolidated Statements of Cash Flows (Unaudited) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsUnaudited Consolidated Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 100080 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 8 false false R9.htm 100090 - Disclosure - Liquidity and Going Concern Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureLiquidityAndGoingConcern Liquidity and Going Concern Notes 9 false false R10.htm 100100 - Disclosure - Fair Value Measurements Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureFairValueMeasurements Fair Value Measurements Notes 10 false false R11.htm 100110 - Disclosure - Investments Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureInvestments Investments Notes 11 false false R12.htm 100120 - Disclosure - Goodwill and Intangible Assets Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureGoodwillAndIntangibleAssets Goodwill and Intangible Assets Notes 12 false false R13.htm 100130 - Disclosure - Significant Agreements and Contracts Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureSignificantAgreementsAndContracts Significant Agreements and Contracts Notes 13 false false R14.htm 100140 - Disclosure - Debt Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureDebt Debt Notes 14 false false R15.htm 100150 - Disclosure - Stockholders' Equity Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureStockholdersEquity Stockholders' Equity Notes 15 false false R16.htm 100160 - Disclosure - Stock Based Compensation Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensation Stock Based Compensation Notes 16 false false R17.htm 100170 - Disclosure - Commitments and Contingencies Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 17 false false R18.htm 100180 - Disclosure - Income Taxes Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxes Income Taxes Notes 18 false false R19.htm 100190 - Disclosure - Net Loss Per Share Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureNetLossPerShare Net Loss Per Share Notes 19 false false R20.htm 100200 - Disclosure - Segment Information Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureSegmentInformation Segment Information Notes 20 false false R21.htm 100210 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 21 false false R22.htm 100220 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPolicies 22 false false R23.htm 100230 - Disclosure - Fair Value Measurements (Tables) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureFairValueMeasurements 23 false false R24.htm 100240 - Disclosure - Goodwill and Intangible Assets (Tables) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureGoodwillAndIntangibleAssetsTables Goodwill and Intangible Assets (Tables) Tables http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureGoodwillAndIntangibleAssets 24 false false R25.htm 100250 - Disclosure - Debt (Tables) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureDebtTables Debt (Tables) Tables http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureDebt 25 false false R26.htm 100260 - Disclosure - Stock Based Compensation (Tables) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationTables Stock Based Compensation (Tables) Tables http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensation 26 false false R27.htm 100270 - Disclosure - Commitments and Contingencies (Tables) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingencies 27 false false R28.htm 100280 - Disclosure - Net Loss Per Share (Tables) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureNetLossPerShare 28 false false R29.htm 100290 - Disclosure - Segment Information (Tables) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureSegmentInformationTables Segment Information (Tables) Tables http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureSegmentInformation 29 false false R30.htm 100300 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Revenue Disaggregated by Product and Service Type (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesScheduleOfRevenueDisaggregatedByProductAndServiceTypeDetails Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Revenue Disaggregated by Product and Service Type (Details) Details 30 false false R31.htm 100310 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureBasisOfPresentationAndSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Basis of Presentation and Summary of Significant Accounting Policies - Additional Information (Details) Details 31 false false R32.htm 100320 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) Details 32 false false R33.htm 100330 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 33 false false R34.htm 100340 - Disclosure - Fair Value Measurements - Summary of Derivative Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfDerivativeLiabilitiesMeasuredAtFairValueUsingSignificantUnobservableInputsLevel3Details Fair Value Measurements - Summary of Derivative Liabilities Measured at Fair Value Using Significant Unobservable Inputs (Level 3) (Details) Details 34 false false R35.htm 100350 - Disclosure - Investment - Celularity - Additional Information - (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureInvestmentCelularityAdditionalInformationDetails Investment - Celularity - Additional Information - (Details) Details 35 false false R36.htm 100360 - Disclosure - Investments - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails Investments - Additional Information (Details) Details 36 false false R37.htm 100370 - Disclosure - Investments - NANTibody - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureInvestmentsNantibodyAdditionalInformationDetails Investments - NANTibody - Additional Information (Details) Details 37 false false R38.htm 100380 - Disclosure - Investments - NantStem - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureInvestmentsNantstemAdditionalInformationDetails Investments - NantStem - Additional Information (Details) Details 38 false false R39.htm 100390 - Disclosure - Goodwill and Intangible Assets - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureGoodwillAndIntangibleAssetsAdditionalInformationDetails Goodwill and Intangible Assets - Additional Information (Details) Details 39 false false R40.htm 100400 - Disclosure - Goodwill and Intangible Assets - Summary of Company's Identifiable Intangible Assets (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureGoodwillAndIntangibleAssetsSummaryOfCompanySIdentifiableIntangibleAssetsDetails Goodwill and Intangible Assets - Summary of Company's Identifiable Intangible Assets (Details) Details 40 false false R41.htm 100410 - Disclosure - Goodwill and Intangible Assets - Schedule of Estimated Future Amortization Expense Related to Intangible Assets (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureGoodwillAndIntangibleAssetsScheduleOfEstimatedFutureAmortizationExpenseRelatedToIntangibleAssetsDetails Goodwill and Intangible Assets - Schedule of Estimated Future Amortization Expense Related to Intangible Assets (Details) Details 41 false false R42.htm 100420 - Disclosure - Significant Agreements and Contracts - Romeg License Agreement -Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureSignificantAgreementsAndContractsRomegLicenseAgreementAdditionalInformationDetails Significant Agreements and Contracts - Romeg License Agreement -Additional Information (Details) Details 42 false false R43.htm 100430 - Disclosure - Significant Agreements and Contracts - Zhengzhou Fortune Bioscience Co., Ltd. - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureSignificantAgreementsAndContractsZhengzhouFortuneBioscienceCoLtdAdditionalInformationDetails Significant Agreements and Contracts - Zhengzhou Fortune Bioscience Co., Ltd. - Additional Information (Details) Details 43 false false R44.htm 100440 - Disclosure - Significant Agreements and Contracts - Acquisition of Virex Health, Inc. - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureSignificantAgreementsAndContractsAcquisitionOfVirexHealthIncAdditionalInformationDetails Significant Agreements and Contracts - Acquisition of Virex Health, Inc. - Additional Information (Details) Details 44 false false R45.htm 100450 - Disclosure - Significant Agreements and Contracts - Acquisition of ACEA Therapeutics, Inc. - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureSignificantAgreementsAndContractsAcquisitionOfACEATherapeuticsIncAdditionalInformationDetails Significant Agreements and Contracts - Acquisition of ACEA Therapeutics, Inc. - Additional Information (Details) Details 45 false false R46.htm 100460 - Disclosure - Debt - 2018 Purchase Agreement and Indenture for Scilex and Bridge Loan Agreement - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureDebt2018PurchaseAgreementAndIndentureForScilexAndBridgeLoanAgreementAdditionalInformationDetails Debt - 2018 Purchase Agreement and Indenture for Scilex and Bridge Loan Agreement - Additional Information (Details) Details 46 false false R47.htm 100470 - Disclosure - Debt - 2018 Purchase Agreement and Indenture for Scilex - Schedule of Long-Term Debt and Unamortized Discount Balances (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureDebt2018PurchaseAgreementAndIndentureForScilexScheduleOfLongTermDebtAndUnamortizedDiscountBalancesDetails Debt - 2018 Purchase Agreement and Indenture for Scilex - Schedule of Long-Term Debt and Unamortized Discount Balances (Details) Details 47 false false R48.htm 100480 - Disclosure - Debt - Future Minimum Payments (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureDebtFutureMinimumPaymentsDetails Debt - Future Minimum Payments (Details) Details 48 false false R49.htm 100490 - Disclosure - Debt - Schedule of Borrowings under ACEA Significant Debt Arrangements (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureDebtScheduleOfBorrowingsUnderAceaSignificantDebtArrangementsDetails Debt - Schedule of Borrowings under ACEA Significant Debt Arrangements (Details) Details 49 false false R50.htm 100500 - Disclosure - Stockholders' Equity - At-the-Market Sales Agreement - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureStockholdersEquityAtthemarketSalesAgreementAdditionalInformationDetails Stockholders' Equity - At-the-Market Sales Agreement - Additional Information (Details) Details 50 false false R51.htm 100510 - Disclosure - Stock Based Compensation - 2019 Stock Incentive Plan - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensation2019StockIncentivePlanAdditionalInformationDetails Stock Based Compensation - 2019 Stock Incentive Plan - Additional Information (Details) Details 51 false false R52.htm 100520 - Disclosure - Stock Based Compensation - Summary of Stock Option Activity (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockOptionActivityDetails Stock Based Compensation - Summary of Stock Option Activity (Details) Details 52 false false R53.htm 100530 - Disclosure - Stock Based Compensation - Summary of RSU Activity (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfRSUActivityDetails Stock Based Compensation - Summary of RSU Activity (Details) Details 53 false false R54.htm 100540 - Disclosure - Stock Based Compensation - Scilex Holding Company - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationScilexHoldingCompanyAdditionalInformationDetails Stock Based Compensation - Scilex Holding Company - Additional Information (Details) Details 54 false false R55.htm 100550 - Disclosure - Stock Based Compensation - Employee Stock Purchase Plan - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationEmployeeStockPurchasePlanAdditionalInformationDetails Stock Based Compensation - Employee Stock Purchase Plan - Additional Information (Details) Details 55 false false R56.htm 100560 - Disclosure - Stock Based Compensation - CEO Performance Award - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureStockBasedCompensationCEOPerformanceAwardAdditionalInformationDetails Stock Based Compensation - CEO Performance Award - Additional Information (Details) Details 56 false false R57.htm 100570 - Disclosure - Commitments and Contingencies - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesAdditionalInformationDetails Commitments and Contingencies - Additional Information (Details) Details 57 false false R58.htm 100580 - Disclosure - Commitments and Contingencies - Supplemental Quantitative Information Related to Leases (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesSupplementalQuantitativeInformationRelatedToLeasesDetails Commitments and Contingencies - Supplemental Quantitative Information Related to Leases (Details) Details 58 false false R59.htm 100590 - Disclosure - Commitments and Contingencies - Schedule of Operating Lease Liability Maturities (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureCommitmentsAndContingenciesScheduleOfOperatingLeaseLiabilityMaturitiesDetails Commitments and Contingencies - Schedule of Operating Lease Liability Maturities (Details) Details 59 false false R60.htm 100600 - Disclosure - Income Taxes - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureIncomeTaxesAdditionalInformationDetails Income Taxes - Additional Information (Details) Details 60 false false R61.htm 100610 - Disclosure - Net Loss Per Share - Reconciliation of Basic and Diluted Loss Per Share (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureNetLossPerShareReconciliationOfBasicAndDilutedLossPerShareDetails Net Loss Per Share - Reconciliation of Basic and Diluted Loss Per Share (Details) Details 61 false false R62.htm 100620 - Disclosure - Net Loss Per Share - Components of Outstanding Securities (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/DisclosureNetLossPerShareComponentsOfOutstandingSecuritiesDetails Net Loss Per Share - Components of Outstanding Securities (Details) Details 62 false false R63.htm 100630 - Disclosure - Segment Information - Additional Information (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureSegmentInformationAdditionalInformationDetails Segment Information - Additional Information (Details) Details 63 false false R64.htm 100640 - Disclosure - Segment Information - Summary of Information by Reportable Segments (Details) Sheet http://sorrentotherapeutics.com/20220630/taxonomy/role/Role_DisclosureSegmentInformationSummaryOfInformationByReportableSegmentsDetails Segment Information - Summary of Information by Reportable Segments (Details) Details 64 false false All Reports Book All Reports srne-20220630.htm srne-20220630.xsd srne-20220630_cal.xml srne-20220630_def.xml srne-20220630_lab.xml srne-20220630_pre.xml srne-ex31_1.htm srne-ex31_2.htm srne-ex32_1.htm http://fasb.org/us-gaap/2021-01-31 http://xbrl.sec.gov/dei/2021q4 true true